D-Chiral Inositol

*Promote liver lipid metabolism;
*Insulin sensitization, hypoglycemia, anti-oxidation.
Packing specification: 25 kg/barrel
Uses: raw materials for health care products, dietary supplements

D-chiral inositol (DCI) is a stereoisomer of inositol. It is an important part of phosphoinositol glucan (IP-gly), the second messenger of insulin. It cannot be synthesized directly in the body and can only be synthesized externally. Obtained by source means. It can regulate blood sugar and improve the symptoms of people with diabetes (especially those with type 2 diabetes). As an insulin receptor sensitizer discovered in research, it can effectively promote insulin function, lower blood sugar, blood triglyceride levels, etc., and play an extremely important role in the signal transduction process of the hypoglycemic hormone-insulin.
When the body lacks enough D-chiral inositol, it will lead to insulin resistance. Insulin resistance is not only the basis for the onset of type II diabetes, but also the main line that runs through a variety of metabolic-related diseases, is the link that connects them, and is the cause of these diseases. The basis of common pathophysiology. Insulin resistance is a problem with the receptor and signal transduction system (ie receiver) of insulin in the human body. Supplementing D-chiral inositol can improve the sensitivity of body tissues to insulin, eliminate insulin resistance, regulate the body's physiological functions and metabolic balance, thereby reducing the incidence of diabetes.

D-chiral inositol is a nutrient present in the human body, which allows the body's cells to better recognize it and has no rejection reaction to him. In 1994, the U.S. Dietary Supplement Health and Education Act certified D-Chiral Inositol as a dietary supplement.